BlackRock’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $28.2K | Hold |
|
|||||
|
2025
Q1 | $31.7K | Hold |
|
|||||
|
2024
Q4 | $57.1K | Sell |
|
|||||
|
2024
Q3 | $87K | Sell |
|
|||||
|
2024
Q2 | $131K | Sell |
|
|||||
|
2024
Q1 | $276K | Buy |
|
|||||
|
2023
Q4 | $127K | Sell |
|
|||||
|
2023
Q3 | $93.5K | Sell |
|
|||||
|
2023
Q2 | $1M | Buy |
|
|||||
|
2023
Q1 | $1.56M | Buy |
|
|||||
|
2022
Q4 | $774K | Buy |
|
|||||
|
2022
Q3 | $2.07M | Sell |
|
|||||
|
2022
Q2 | $1.31M | Sell |
|
|||||
|
2022
Q1 | $1.59M | Buy |
|
|||||
|
2021
Q4 | $1.89M | Buy |
|
|||||
|
2021
Q3 | $1.55M | Sell |
|
|||||
|
2021
Q2 | $1.8M | Sell |
|
|||||
|
2021
Q1 | $7.48M | Buy |
|
|||||
|
2020
Q4 | $8.69M | Buy |
|
|||||
|
2020
Q3 | $31.7M | Buy |
|
|||||
|
2020
Q2 | $20.8M | Buy |
|
|||||
|
2020
Q1 | $1.78M | Buy |
|
|||||
|
2019
Q4 | $709K | Buy |
|
|||||
|
2019
Q3 | $525K | Buy |
|
|||||
|
2019
Q2 | $514K | Buy |
|
|||||
|
2019
Q1 | $392K | Buy |
|
|||||
|
2018
Q4 | $303K | Buy |
|
|||||
|
2018
Q3 | $325K | Buy |
|
|||||
|
2018
Q2 | $323K | Buy |
|
|||||
|
2018
Q1 | $249K | Sell |
|
|||||
|
2017
Q4 | $328K | Buy |
|
|||||
|
2017
Q3 | $326K | Sell |
|
|||||
|
2017
Q2 | $335K | Buy |
|
|||||
|
2017
Q1 | $327K | Buy |
|